Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $36.33 | 2 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $18.60 | 1 | $0 (2020) |
| Lilly USA, LLC | $17.73 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $36.33 | 2 | AstraZeneca Pharmaceuticals LP ($18.60) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/23/2020 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Oncology | ||||||
| 01/16/2020 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 961 | 1,657 | $156,970 | $40,095 |
| 2022 | 17 | 951 | 1,760 | $174,690 | $42,088 |
| 2021 | 20 | 1,250 | 2,076 | $204,767 | $49,974 |
| 2020 | 15 | 799 | 1,444 | $141,098 | $35,855 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 323 | 607 | $65,237 | $15,970 | 24.5% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 64 | 321 | $26,081 | $6,930 | 26.6% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 42 | 66 | $15,687 | $4,188 | 26.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 122 | 152 | $15,238 | $4,046 | 26.6% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2023 | 26 | 36 | $7,272 | $1,835 | 25.2% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 20 | 55 | $6,611 | $1,772 | 26.8% |
| 86255 | Screening test for antibody to noninfectious agent | Facility | 2023 | 107 | 112 | $5,536 | $1,496 | 27.0% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2023 | 36 | 44 | $3,494 | $937.14 | 26.8% |
| 84165 | Protein measurement, serum | Facility | 2023 | 51 | 58 | $2,656 | $692.50 | 26.1% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 59 | 69 | $2,484 | $621.33 | 25.0% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Facility | 2023 | 39 | 46 | $2,632 | $581.70 | 22.1% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 60 | 67 | $2,211 | $534.28 | 24.2% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 12 | 24 | $1,831 | $491.79 | 26.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 304 | 639 | $68,526 | $16,360 | 23.9% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 66 | 370 | $33,784 | $8,099 | 24.0% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 52 | 76 | $20,960 | $4,401 | 21.0% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 127 | 159 | $17,195 | $4,091 | 23.8% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2022 | 27 | 56 | $7,308 | $1,839 | 25.2% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2022 | 14 | 25 | $5,053 | $1,381 | 27.3% |
| 86255 | Screening test for antibody to noninfectious agent | Facility | 2022 | 84 | 93 | $3,348 | $1,212 | 36.2% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2022 | 36 | 43 | $3,419 | $878.64 | 25.7% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2022 | 65 | 70 | $2,460 | $666.26 | 27.1% |
| 84165 | Protein measurement, serum | Facility | 2022 | 44 | 49 | $1,568 | $648.42 | 41.4% |
| 88333 | Pathology cytologic examination of specimen during surgery, initial site | Facility | 2022 | 11 | 13 | $2,291 | $630.59 | 27.5% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Facility | 2022 | 34 | 36 | $2,412 | $475.50 | 19.7% |
About Dr. Kate Serdy, MD
Dr. Kate Serdy, MD is a Anatomic Pathology healthcare provider based in Jefferson Hills, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2015. The National Provider Identifier (NPI) number assigned to this provider is 1154700805.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kate Serdy, MD has received a total of $36.33 in payments from pharmaceutical and medical device companies, with $36.33 received in 2020. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($36.33).
As a Medicare-enrolled provider, Serdy has provided services to 3,961 Medicare beneficiaries, totaling 6,937 services with total Medicare billing of $168,012. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Location Jefferson Hills, PA
- Active Since 05/28/2015
- Last Updated 10/02/2020
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1154700805
Products in Payments
- TAGRISSO (Drug) $18.60
- VERZENIO (Drug) $17.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.